Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

5.36
Delayed Data
As of Apr 28
 +0.2999 / +5.93%
Today’s Change
4.86
Today|||52-Week Range
8.06
+5.10%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close5.06
Today’s open5.06
Day’s range5.05 - 5.36
Volume1,000
Average volume (3 months)12,325
Market cap$129.9M
Dividend yield--
Data as of 3:38pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-13.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-41.23%
P/E ratio--
Price/Sales19.84
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...-0.10-2.56%
PLXProtalix Biotherapeu...-0.07-6.99%
QUREUniqure NV-0.10-1.83%
PSTIPluristem Therapeuti...-0.01-0.69%
Data as of 4:06pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.6M
Net profit margin-299.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Tel Aviv

Forecasts